Genprex
GNPX • NASDAQ
Genprex is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ryan Confer, with a market cap of $4.1M.
Market Cap$4.1M
Employees25.0
CEORyan Confer
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Genprex FAQ
Common questions about Genprex
Genprex is scheduled to report earnings for Q1 2026 on May 11, 2026.
Genprex has approximately 25 employees.